Appeal 2007-3396
Application 1 11008,592
THE CLAIMS
Claims 1-7 are pending. Bayer does not provide separate arguments
for subgroups of claims so we treat the claims as standing or falling together
and select the sole independent claim as representative of the group.3
Claim 1 defines the invention as follow^:^
A process for the production of polyurethane integral
skin foams comprising
(1) preparing a polyol formulation (A) comprising
a) at least one polyol component having a OH
number of from 20 to 1050 and a
functionality of from 2 to 6, or a mixture of
polyol components having a mean OH
number of from 250 to 650 and a mean
functionality of from 2.5 to 5,
b) optionally, one or more chain extenders
and/or crosslinkers,
c) optionally, one or more activators,
d) water and
e) optionally, one or more additives and
auxiliary substances, and
(2) reacting formulation (A) with an isocyanate
component (B) con~prising
f ) one or more organic and/or modified organic
polyisocyanates and/or polyisocyanate pre-
polymers and
g) one or more inorganic zeolites.
The Board is obligated to construe pending claims as broadly as their
terms reasonably allow.5 The phrase "polyurethane integral skin foams"
37 C.F.R. tj 41.37(c)(l)(vii).
4 Claim language is reproduced from the claim appendix of the Appeal Brief
(Br .) .
In re Zletr, 893 F.2d 3 19, 321, 13 USPQ2d 1320, 1322 (Fed. Cir. 1989).
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: September 9, 2013